USD
$0.00
(0.00%
)At Close (As of Oct 24, 2025)
$742.06M
Market Cap
408.5
P/E Ratio
0.02
EPS
$19.00
52 Week High
$6.11
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $102M |
| Total Revenue | $106M |
| Cost Of Revenue | $3.9M |
| Costof Goods And Services Sold | $3.9M |
| Operating Income | $16M |
| Selling General And Administrative | $16M |
| Research And Development | $12M |
| Operating Expenses | $86M |
| Investment Income Net | - |
| Net Interest Income | $1.5M |
| Interest Income | $1.5M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.6M |
| Income Before Tax | $23M |
| Income Tax Expense | $5.3M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $18M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $16M |
| Ebitda | $18M |
| Net Income | $12M |
| Field | Value (USD) |
|---|---|
| Total Assets | $125M |
| Total Current Assets | $65M |
| Cash And Cash Equivalents At Carrying Value | $12M |
| Cash And Short Term Investments | $12M |
| Inventory | $6.3M |
| Current Net Receivables | $29M |
| Total Non Current Assets | $61M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $273K |
| Intangible Assets Excluding Goodwill | $273K |
| Goodwill | - |
| Investments | - |
| Long Term Investments | $25M |
| Short Term Investments | $15M |
| Other Current Assets | $2.6M |
| Other Non Current Assets | - |
| Total Liabilities | $27M |
| Total Current Liabilities | $20M |
| Current Accounts Payable | $108K |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.4M |
| Total Non Current Liabilities | $7.5M |
| Capital Lease Obligations | $1.6M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $1.6M |
| Other Current Liabilities | $15M |
| Other Non Current Liabilities | $7K |
| Total Shareholder Equity | $63M |
| Treasury Stock | - |
| Retained Earnings | -$73M |
| Common Stock | $86K |
| Common Stock Shares Outstanding | $102M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$3.6M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $1.6M |
| Capital Expenditures | $2.3M |
| Change In Receivables | - |
| Change In Inventory | -$2.1M |
| Profit Loss | - |
| Cashflow From Investment | -$20M |
| Cashflow From Financing | $2.1M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $18M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $102M |
| Total Revenue | $106M |
| Cost Of Revenue | $3.9M |
| Costof Goods And Services Sold | $3.9M |
| Operating Income | $16M |
| Selling General And Administrative | $16M |
| Research And Development | $12M |
| Operating Expenses | $86M |
| Investment Income Net | - |
| Net Interest Income | $1.5M |
| Interest Income | $1.5M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.6M |
| Income Before Tax | $23M |
| Income Tax Expense | $5.3M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $18M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $16M |
| Ebitda | $18M |
| Net Income | $12M |
| Field | Value |
|---|---|
| Ex Dividend Date | 2023-01-13 |
| Declaration Date | 2022-12-27 |
| Record Date | 2023-01-05 |
| Payment Date | 2023-01-12 |
| Amount | 0.24 |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None